Bullish option flow detected in Verona Pharma with 4,574 calls trading, 1.6x expected, and implied vol increasing almost 3 points to 79.69%. Dec-24 30 calls and Jul-24 20 calls are the most active options, with total volume in those strikes near 3,100 contracts. The Put/Call Ratio is 0.02. Earnings are expected on August 1st.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRNA:
- Verona Pharma call volume above normal and directionally bullish
- Verona Pharma price target raised to $38 from $32 at Truist
- Unusually active option classes on open June 27th
- Verona approval label may benefit Regeneron, says RBC Capital
- Ligand earns $5.8M milestone payment following FDA approval of Ohtuvayre